Sending the signal: Molecular mechanisms regulating glucose uptake

Medicine and Science in Sports and Exercise

Volumn 36, Issue 7, 2004, Pages 1212-1217

  Krook, Anna ^a   Wallberg Henriksson, Harriet ^a   Zierath, Juleen R ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 AMP activated kinase; Acetyl CoA carboxylase; GLUT4; Insulin receptor substrates; Phosphatidylinositol 3 kinase

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE PHOSPHATE; ACETYL COENZYME A CARBOXYLASE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

BIOTINYLATION; CONFERENCE PAPER; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPOXIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 3042851621     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000132387.25853.3B     Document Type: Conference Paper

References (50)

1. ALESSI, D. R., S. R. JAMES, C. P. DOWNES, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7:261-269, 1997.
2. ARAKI, E., M. A. LIPES, M. E. PATTI, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190, 1994.
3. BANDYOPADHYAY, G., M. L. STANDAERT, L. ZHAO, et al. Activation of protein kinase C (α, β, and ζ) by insulin in 3T3/L1 cells: transfection studies suggest a role for PKC-ζ in glucose transport. J. Biol. Chem. 272:2551-2558, 1997.
4. BAUMANN, C. A., V. RIBON, M. KANZAKI, et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407:147-148, 2000.
5. BEESON, M., M. P. SAJAN, M. DIZON, et al. Activation of protein kinase C-ζ by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in Type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52:1926-1934, 2003.
6. BJÖRNHOLM, M., A. R. HE, A. ATTERSAND, et al. Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45:1697-1702, 2002.
7. BJÖRNHOLM, M., Y. KAWANO, M. LEHTIHET, and J. R. ZIERATH. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in skeletal muscle from NIDDM subjects following in vivo insulin stimulation. Diabetes 46:524-527, 1997.
8. BROZINICK, J. T., JR., B. R. ROBERTS, and G. L. DOHM. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52:935-941, 2003.
9. CHIBALIN, A. V., M. YU, J. W. RYDER, et al. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin receptor substrates 1 and 2. Proc. Natl. Acad. Sci. USA 97:38-43, 2000.
10. CHO, H., J. MU, J. KIM, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β). Science 292:1728-1731, 2001.
11. CHO, H., J. L. THORVALDSEN, Q. CHU, F. FENG, and M. J. BIRNBAUM. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276: 38349-38352, 2001.
12. Cusi, K., K. MAEZONO, A. OSMAN, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105:311-320, 2000.
13. DOHM, G. L., E. B. TAPSCOTT, W. J. PORIES, et al. An in vitro human skeletal muscle preparation suitable for metabolic studies: decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82:486-494, 1988.
14. DUNAIF, A., X. WU, A. LEE, and E. DIAMANTI-KANDARAKIS. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am. J. Physiol. (Endocrinol. Metab). 281:E392-E399, 2001.
15. ERIKSSON, J., L. KORANYI, R. BOUREY, et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 35:143-147, 1992.
16. GARVEY, W. T., L. MAIANU, J. A. HANCOCK, A. M. GOLICHOWSKI, and A. M. BARON. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IDM, GDM, and NIDDM. Diabetes. 41:465-475, 1992.
17. GOODYEAR, L. J., F. GIORGINO, L. A. SHERMAN, J. CAREY, R. J. SMITH, and G. L. DOHM. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204, 1995.
18. HENRIKSEN, J. E., F. ALFORD, A. HANDBERG, et al. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94:1196-1204, 1994.
19. HOUMARD, J. A., C. D. SHAW, M. S. HICKEY, and C. J. TANNER. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am. J. Physiol. (Endocrinol. Metab). 277:E1055-E1060, 1999.
20. HOUMARD, J. A., M. H. SHINEBARGER, P. L. DOLAN, et al. Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am. J. Physiol. (Endocrinol. Metab). 264:E896-E901, 1993.
21. ISAKSSON, B., L. STROMMER, H. FRIESS, et al. Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients. Pancrease 26:173-177, 2003.
22. JIANG, Z. Y., Q. L. ZHOU, K. A. COLEMAN, M. CHOUINARD, Q. BOESE, and M. P. CZECH. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100:7569-7574, 2003.
23. KABURAGI, Y., S. SATOH, H. TAMEMOTO, et al. Role of the insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transporter and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272:25839-25844, 1997.
24. KANE, S., H. SANO, S. C. H. LIU, et al. A method to identify serine kinase substrates: Akt phosphorylates a novel adipocyte protein with a Rab-GTPase-activating protein (GAP) domain. J. Biol. Chem. 277:22115-22118, 2002.
25. KATOME, T., T. OBATA, R. MATSUSHIMA, et al. Use of RNA Interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J. Biol. Chem. 278:28312-28323, 2003.
26. KEROUZ, N. J., D. HORSCH, S. PONS, and C. R. KAHN. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100, 1997.
27. KIM, Y.-B., K. KOTANI, T. P. CIARALDI, R. R. HENRY, and B. B. KAHN. Insulin-stimulated protein kinase C λ/ζ activity is reduced in skeletal muscle of humans with obesity and Type 2 diabetes: reversal with weight reduction. Diabetes 52:1935-1942, 2003.
28. KIM, Y. B., S. E. NIKOULINA, T. P. CIARALDI, R. R. HENRY, and B. B. KAHN. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J. Clin. Invest. 104:733-741, 1999.
29. KIRWAN, J. P., L. F. DEL AGUILA, J. M. HERNANDEZ, et al. Regular exercise enhances activation of IRS-1-associated PI3-Kinase in human skeletal muscle. J. Appl. Physiol. 88:797-803, 2000.
30. KLEIN, H. H., H. VESTERGAARD, G. KOTZKE, and O. PEDERSEN. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 44:1310-1317, 1995.
31. KOISTINEN, H. A., D. GALUSKA, A. V. CHIBALIN, et al. 5-Aminoimidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with Type 2 diabetes. Diabetes 52:1066-1072, 2003.
32. KROOK, A., M. BJÖRNHOLM, D. GALUSKA, et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284-292, 2000.
33. KROOK, A., R. A. RTH, X. J. JIANG, J. R. ZIERATH, and H. WALLBERG-HENRIKSSON. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent diabetic subjects. Diabetes 47:1281-1286, 1998.
34. KROOK, A., J. P. WHITEHEAD, S. P. DOBSON, et al. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphatidylinositol 3-kinase activation alone is not sufficient for the meditation of insulin's metabolic and mitogenic effects. J. Biol. Chem. 272:30208-30214, 1997.
35. MU, J., J. T. J. BROZINICK, O. VALLADARES, M. BUCAN, and M. J. BIRNBAUM. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell. 7:1085-1094, 2001.
36. PERRINI, S., J. HENRIKSSON, J. R. ZIERATH, and U. WIDEGREN. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53:21-24, 2004.
37. RONDINONE, C. M., L. M. WANG, P. LÖNNROTH, C. WESSLAU, J. H. PIERCE, and U. SMITH. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 94:4171-4175, 1997.
38. RYDER, J. W., J. YANG, D. GALUSKA, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49:647-654, 2000.
39. SANO, H., S. KANE, E. SANO, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278:14599-14602, 2003.
40. SHAO, J., H. YAMASHITA, L. QIAO, B. DRAZNIN, and J. E. FRIEDMAN. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes 51:19-29, 2002.
41. SMITH-HALL, J., S. PONS, M. E. PATTI, et al. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36:8304-8310, 1997.
42. SONG, X. M., M. FIEDLER, D. R. GALUSKA, et al. 5-aminoimidazole-4- carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45:56-65, 2002.
43. STOKOE, D., L. R. STEPHENS, T. COPELAND, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570, 1997.
44. TAMEMOTO, H., T. KADOWAKI, K. TOBE, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:128-129, 1994.
45. TANNER, C. J., T. R. KOVES, R. L. CORTRIGHT, et al. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in middle-aged men. Am. J. Physiol. (Endocrinol. Metab). 282:E147-E153, 2002.
46. VAAG, A., J. E. HENRIKSEN, and H. BECK-NIELSEN. Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:782-788, 1992.
47. WHITHERS, D. J., J. S. GUTIERREZ, H. TOWERY, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904, 1998.
48. WIDEGREN, U., X. J. JIANG, A. KROOK, et al. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB. J. 12:1379-1389, 1998.
49. ZIERATH, J. R., L. HE, A. GUMA, E. WAHLSTRÖM, A. KLIP, and H. WALLBERG-HENRIKSSON. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996.
50. ZIERATH, J. R., A. KROOK, and H. WALLBERG-HENRIKSSON. Insulin action and insulin resistance in human skeletal musle. Diabetologia 43:821-835, 2000.